InVivoScribe Technologies, Inc. Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire Clinically-Actionable Genetic Test Menu
12/6/2012 9:43:15 AM
More...
|
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan
12/5/2012 9:56:58 AM
More...
|
InVivoScribe Technologies, Inc. Announces Collaboration Agreement to Develop Companion Diagnostic Test
2/16/2011 8:32:31 AM
More...
|
TrovaGene, Inc. Announces that its NPM1 Technology is Now Part of Laboratory Corporation of America Holdings (LabCorp) (LH)'s and InVivoScribe Technologies, Inc.'s AML Cancer Testing Services
3/31/2010 11:24:23 AM
More...
|